Abstract:Bronchial asthma is a heterogeneous disease characterized by persistent respiratory system inflammation, airway hyperreactivity, and airflow obstruction. Airway remodeling, defined as changes in airway wall structure such as extensive epithelial damage, airway smooth muscle hypertrophy, collagen deposition, and subepithelial fibrosis, is a key feature of asthma. Lung fibrosis is a common occurrence in the pathogenesis of fatal and long-term asthma, and it is associated with disease severity and resistance to therapy. It can thus be regarded as an irreversible consequence of asthma-induced airway inflammation and remodeling. Asthma heterogeneity presents several diagnostic challenges, particularly in distinguishing between chronic asthma and other pulmonary diseases characterized by disruption of normal lung architecture and functions, such as chronic obstructive pulmonary disease. The search for instruments that can predict the development of irreversible structural changes in the lungs, such as chronic components of airway remodeling and fibrosis, is particularly difficult. To overcome these challenges, significant efforts are being directed toward the discovery and investigation of molecular characteristics and biomarkers capable of distinguishing between different types of asthma as well as between asthma and other pulmonary disorders with similar structural characteristics. The main features of bronchial asthma etiology, pathogenesis, and morphological characteristics as well as asthma-associated airway remodeling and lung fibrosis as successive stages of one process will be discussed in this review. The most common murine models and biomarkers of asthma progression and post-asthmatic fibrosis will also be covered. The molecular mechanisms and key cellular players of the asthmatic process described and systematized in this review are intended to help in the search for new molecular markers and promising therapeutic targets for asthma prediction and therapy.

Review of advances in refractory asthma and new evaluation technology

Advances in Pulmonary Rehabilitation for Children with Bronchial Asthma.

Research progress on accurate treatment of bronchial asthma

Status and prospects: personalized treatment and biomarker for airway remodeling in asthma

Status and Progress in Treatment of Bronchial Asthma

Recent Advance in Regulatory T Cells and Bronchial Asthma

Advances in Asthma Treatment

Reasearch Progress on the Role of Neutrophils in Asthma

New insights into asthma pathogenesis and treatment

Progress of Drug Treatment of Asthma

Airway Remodeling in Asthma: Mechanisms, Diagnosis, Treatment, and Future Directions

Bronchial thermoplasty for severe asthma: potential mechanisms and response markers

Molecular Pathways and Potential Therapeutic Targets of Refractory Asthma

Immunologic aspects of asthma: from molecular mechanisms to disease pathophysiology and clinical translation

Research progress of targeted therapy for bronchial asthma

Advances in Diagnosis and Therapy of Difficult-Treat Asthma

Reshaping respiratory care: potential advances in inhaled pharmacotherapy in asthma

New therapies and management strategies in the treatment of asthma: patient-focused developments

Interventional pulmonology for chronic inflammatory airway diseases

Bronchial Asthma, Airway Remodeling and Lung Fibrosis as Successive Steps of One Process

Advancing Treatment Strategies: A Comprehensive Review of Drug Delivery Innovations for Chronic Inflammatory Respiratory Diseases